Under the patronage of His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince, Prime Minister, and Chairman of the Board of Directors of the Riyadh Biotechnology Center Foundation, the capital city of Riyadh is preparing to host the fourth edition of the "Riyadh Global Biotechnology Summit." This prominent global event is scheduled to take place from September 14 to 16, 2026, and is organized by the Ministry of National Guard Health Affairs, represented by the King Abdullah International Medical Research Center (KAIMRC), in strategic partnership with the Ministry of Investment.
Enhancing Saudi Arabia's leadership in the biotechnology sector
This summit marks a pivotal step in the Kingdom of Saudi Arabia's journey towards achieving global leadership in the biotechnology sector, a sector that enjoys exceptional attention from the wise leadership. The summit's objectives align directly with the goals of the "National Biotechnology Strategy" launched by His Royal Highness the Crown Prince, which aims to make the Kingdom a global hub for biotechnology by 2030 and to lead innovation in the Middle East and North Africa region.
Through this hosting, the Kingdom seeks to localize advanced pharmaceutical industries, enhance health and pharmaceutical security, and diversify the national economy by creating promising investment opportunities in the fields of medical research and genomics.
A global platform for innovation and strategic partnerships
The Riyadh Global Biotechnology Summit is one of the most important international platforms, bringing together leading minds and experts in the field. The summit will see a wide attendance from government officials, decision-makers, CEOs of major global pharmaceutical and biotechnology companies, as well as prominent scientists and experts.
The summit sessions will focus on discussing the latest developments in critical and sensitive areas, including:
- Cell and gene therapy techniques and their future applications.
- The role of artificial intelligence in accelerating drug discoveries and analyzing vital data.
- Developing innovative vaccines and medicines to address global health challenges.
Supporting leadership and empowering the health sector
Commenting on the event, His Royal Highness Prince Abdullah bin Bandar bin Abdulaziz, Minister of the National Guard and a member of the Board of Directors of the Riyadh Biotechnology Center Foundation, expressed his deepest gratitude to His Royal Highness Crown Prince Mohammed bin Salman for his generous patronage of the summit. His Highness emphasized that this patronage reflects the leadership's commitment to empowering the health and research sectors and removing all obstacles to national efforts aimed at achieving significant advancements in the field of biotechnology.
He pointed out that the summit is not only a scientific event, but also a key driver for attracting quality investments and building strategic partnerships between Saudi institutions and global companies, which contributes to the transfer of knowledge and the localization of modern technologies within the Kingdom.
Economic impact and the future of healthcare
The biotechnology sector represents one of the main pillars of the knowledge-based economy within Saudi Vision 2030. The outcomes of this summit are expected to contribute to boosting non-oil GDP and creating thousands of quality jobs for national talents in the fields of science and research.
The summit will also play a crucial role in improving the quality of life and healthcare provided to citizens and residents, by accelerating the arrival of the latest medical treatments and technologies to the Kingdom, and consolidating Riyadh’s position as a global destination for health innovation and sustainable investment.
